Harmonex Neuroscience Research | Dothan, AL

Research site

(Unclaimed)

Location

408 Healthwest Drive, Dothan, Alabama, United States of America

Site insights

Top conditions

Top treatments

Lurasidone

Rapastinel

SHP465

SPN-812

Viloxazine

Lithium

Aripiprazole

Vilazodone

Guanfacine HCl

Divalproex

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 39 total trials

A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

The main aim of this study is learn more about long-term TAK-503 treatment in children and teenagers with ADHD for whom earlier stimulant treatment d...

Active, not recruiting

Attention Deficit Hyperactivity Disorder

Drug: Guanfacine hydrochloride (TAK-503)

Other: Placebo

AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)

The purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated wi...

Active, not recruiting

Autism Spectrum Disorder (ASD)

Drug: Placebo

Drug: AB-2004

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults (D1AMOND)

This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults...

Enrolling

Tourette Disorder

Drug: Ecopipam Hydrochloride

ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and ad...

Enrolling

Autism Spectrum Disorder

Drug: ML-004 Placebo

Drug: ML-004 (IR)/(ER) tablet

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have complete...

Invitation-only

Autism Spectrum Disorder

Drug: ML-004 (IR)/(ER) tablet

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Enrolling

Bipolar I Disorder

Schizophrenia

Drug: Cariprazine Flexible Dose